HR 2821
FDA Modernization Act 3.0
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 13, 2026, 4:11 PM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill, the FDA Modernization Act 3.0, directs the Food and Drug Administration (FDA) to update its regulations to replace references to animal testing with references to ‘nonclinical tests.’ Specifically, it mandates the publication of an interim final rule within a year of the bill’s enactment, revising key sections of the Code of Federal Regulations to align with recent amendments related to clinical trial diversity. The bill also makes a technical amendment to the Federal Food, Drug, and Cosmetic Act.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.